Skip to main content
Tech.euFundingExplorerBeta

Carrick Therapeutics

Targeting aggressive cancer

Total raised
€86M
€86,400,000
Funding rounds
1
Investors
5
distinct backers
Active since
2016-09
latest 2016-09

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood16
base rate 44% for Series A
  • Dormant (no round in 3+ cohort gaps)
  • Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Related news

Similar companies

same sector or country